Assessment of Hepatitis B Vaccine Manufactured by a Modified Process in Healthy Neonates (babies 1 to 10 days old) - Trial 2016-003981-15
Access comprehensive clinical trial information for 2016-003981-15 through Pure Global AI's free database. This phase not specified trial is sponsored by Merck & Co., Inc. and is currently status unknown. The study focuses on Hepatitis B.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2016-003981-15
Trial Details
EU Clinical Trials Register • 2016-003981-15
Assessment of Hepatitis B Vaccine Manufactured by a Modified Process in Healthy Neonates (babies 1 to 10 days old)
Study Focus
Sponsor & Location
Merck & Co., Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
a. Infant born to a mother with no prenatal care.
ICD-10 Classifications
Acute hepatitis B
Acute hepatitis B without delta-agent and without hepatic coma
Acute delta-(super)infection in chronic hepatitis B
Chronic viral hepatitis B without delta-agent
Chronic viral hepatitis B without delta-agent : other and unspecified phase
Data Source
EU Clinical Trials Register
2016-003981-15
Non-Device Trial